COMPANY PROFILE // THE 014 REPORT
Belite Bio, Inc.
BLTE (Nasdaq)
Assembled from 2 government sources in 1.8 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
BELITE BIO, INC is an SEC-registered company in pharmaceutical preparations, incorporated in Cayman Islands, based in San Diego, CA; listed as BLTE (Nasdaq).[source] It has filed 79 documents with the SEC in the last 12 months; the latest is Form 424B5, filed 2026-11-17.[source] Its largest institutional holders on 13F filings are Darwin Global Management, Ltd., Paradigm Biocapital Advisors LP, RTW INVESTMENTS, LP (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- Darwin Global Management, Ltd.$456.6M
- Paradigm Biocapital Advisors LP$189.8M
- RTW INVESTMENTS, LP$110.2M
- MILLENNIUM MANAGEMENT LLC$76.2M
- MAVERICK CAPITAL LTD$61.0M
- EVENTIDE ASSET MANAGEMENT, LLC$60.2M
- DEERFIELD MANAGEMENT COMPANY, L.P.$55.0M
- Holocene Advisors, LP$38.7M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Chuang Hao-Yuan · Chief Financial Officer (Director,Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
- Lin Yu-Hsin · Chief Executive Officer (Director,Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
- MATA NATHAN L. · Chief Scientific Officer (Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
- Scholl Hendrik Peter · Chief Medical Officer (Officer) · latest Form 3 2026-03-18 · filing · LinkedIn search
- Biddle Gary Clark · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
- Chen Wan-Shan · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
- Chen Xiao-Hui · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
- Longo John Michael · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
- Lu Ita · Director · latest Form 3 2026-03-18 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001889109 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-04-30 · in 161 days · Next 20-F due (period ended 2026-12-31; Large accelerated filer) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-17 filing 424B5 · SEC EDGAR
- 2026-11-17 name change Name changed from BELITE BIO, INC · SEC EDGAR
- 2026-11-12 filing 6-K · SEC EDGAR
- 2026-10-19 filing 6-K · SEC EDGAR
- 2026-10-01 filing 144 · SEC EDGAR
- 2026-09-08 filing 6-K · SEC EDGAR
- 2026-08-13 filing 6-K · SEC EDGAR
- 2026-08-12 filing 144 · SEC EDGAR
- 2026-08-12 filing 144 · SEC EDGAR
- 2026-08-11 filing 6-K · SEC EDGAR
- 2026-06-18 filing 144 · SEC EDGAR
- 2026-06-16 filing 144 · SEC EDGAR
- 2026-06-15 filing 6-K · SEC EDGAR
- 2026-05-20 filing 6-K · SEC EDGAR
- 2026-04-21 filing 6-K · SEC EDGAR
- 2026-04-15 filing 144 · SEC EDGAR
- 2026-04-09 filing 144 · SEC EDGAR
- 2026-04-09 filing 144 · SEC EDGAR
- 2026-04-09 filing 144 · SEC EDGAR
- 2026-03-31 filing 6-K · SEC EDGAR
- 2026-03-31 filing Annual report (20-F) · SEC EDGAR
- 2026-03-18 insider First Form 3/4/5 on record for Chuang Hao-Yuan (Chief Financial Officer) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Lin Yu-Hsin (Chief Executive Officer) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for MATA NATHAN L. (Chief Scientific Officer) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Scholl Hendrik Peter (Chief Medical Officer) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Biddle Gary Clark (Director) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Chen Wan-Shan (Director) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Chen Xiao-Hui (Director) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Longo John Michael (Director) · SEC Forms 3/4/5
- 2026-03-18 insider First Form 3/4/5 on record for Lu Ita (Director) · SEC Forms 3/4/5
141 earlier entries
- 2026-03-02 filing 6-K
- 2026-01-30 filing S-8
- 2026-01-27 filing 6-K
- 2025-12-02 filing 424B5
- 2025-12-02 filing 6-K
- 2025-12-01 filing 424B5
- 2025-12-01 filing 6-K
- 2025-12-01 filing 6-K
- 2025-12-01 filing 6-K
- 2025-11-10 filing 6-K
- 2025-10-22 filing F-3ASR
- 2025-10-17 filing 144
- 2025-10-16 filing 144
- 2025-10-14 filing 144
- 2025-10-14 filing 144
- 2025-09-18 filing 144
- 2025-09-08 filing 6-K
- 2025-08-21 filing 144
- 2025-08-11 filing 6-K
- 2025-08-08 filing 424B5
- 2025-08-07 filing 6-K
- 2025-07-02 filing 6-K
- 2025-05-21 filing 144
- 2025-05-21 filing 6-K
- 2025-05-14 filing 6-K
- 2025-04-15 filing 6-K
- 2025-03-28 filing 6-K
- 2025-03-21 filing S-8
- 2025-03-19 filing 144
- 2025-03-18 filing 6-K
- 2025-03-17 filing 6-K
- 2025-03-17 filing 6-K
- 2025-03-17 filing Annual report (20-F)
- 2025-02-27 filing 6-K
- 2025-02-07 filing 424B5
- 2025-02-06 filing 6-K
- 2025-01-27 filing 424B7
- 2025-01-27 filing F-3ASR
- 2025-01-02 filing 144
- 2025-01-02 filing 144
- 2024-11-20 filing 144
- 2024-11-19 filing 144
- 2024-11-12 filing 6-K
- 2024-11-04 filing 6-K
- 2024-10-08 filing 144/A
- 2024-10-08 filing 144/A
- 2024-10-03 filing 144
- 2024-10-03 filing 144
- 2024-10-01 filing S-8
- 2024-09-20 filing 144
- 2024-09-04 filing 144
- 2024-09-03 filing 6-K
- 2024-08-16 filing 144
- 2024-08-14 filing 144
- 2024-08-14 filing 144
- 2024-08-14 filing 144
- 2024-08-09 filing 6-K
- 2024-06-04 filing 144
- 2024-05-30 filing 144
- 2024-05-30 filing 144
- 2024-05-17 filing 144
- 2024-05-16 filing 144
- 2024-05-14 filing 6-K
- 2024-04-29 filing 424B5
- 2024-04-26 filing 6-K
- 2024-03-22 filing 144
- 2024-03-22 filing 6-K
- 2024-03-14 filing 144
- 2024-03-12 filing 6-K
- 2024-03-12 filing Annual report (20-F)
- 2024-03-12 filing 6-K
- 2023-12-28 filing 144
- 2023-12-28 filing 144
- 2023-11-28 filing 144
- 2023-11-16 filing 144
- 2023-11-16 filing 144
- 2023-11-14 filing 6-K
- 2023-11-06 filing 6-K
- 2023-09-19 filing S-8
- 2023-08-31 filing 144
- 2023-08-31 filing 144
- 2023-08-09 filing 6-K
- 2023-07-24 filing 6-K
- 2023-06-16 filing 6-K
- 2023-06-16 filing 424B5
- 2023-06-01 filing 424B5
- 2023-05-31 filing 6-K
- 2023-05-30 filing EFFECT
- 2023-05-30 filing 6-K
- 2023-05-30 filing 424B5
- 2023-05-25 filing CORRESP
- 2023-05-25 filing UPLOAD
- 2023-05-22 filing F-3
- 2023-05-11 filing 6-K
- 2023-05-09 filing EFFECT
- 2023-05-05 filing CORRESP
- 2023-05-05 filing UPLOAD
- 2023-05-01 filing F-3
- 2023-04-25 filing 6-K
- 2023-04-03 filing 6-K
- 2023-03-31 filing Annual report (20-F)
- 2022-12-13 filing 6-K
- 2022-11-18 filing 6-K
- 2022-10-03 filing 6-K
- 2022-09-16 filing 6-K
- 2022-08-22 filing 6-K
- 2022-08-11 filing 6-K
- 2022-07-19 filing 6-K
- 2022-07-08 filing S-8
- 2022-05-12 filing 6-K
- 2022-05-03 filing 6-K
- 2022-04-29 filing 424B4
- 2022-04-28 filing EFFECT
- 2022-04-28 filing EFFECT
- 2022-04-28 filing SEC STAFF LETTER
- 2022-04-27 filing F-1/A
- 2022-04-25 filing FWP
- 2022-04-25 filing CORRESP
- 2022-04-25 filing CORRESP
- 2022-04-25 filing CERT
- 2022-04-22 filing F-1/A
- 2022-04-20 filing F-6
- 2022-04-20 filing 8-A12B
- 2022-04-20 filing FWP
- 2022-04-20 filing F-1/A
- 2022-04-14 filing CORRESP
- 2022-04-11 filing CORRESP
- 2022-04-08 filing UPLOAD
- 2022-04-05 filing SEC STAFF LETTER
- 2022-04-05 filing CORRESP
- 2022-04-05 filing F-1
- 2022-04-01 filing UPLOAD
- 2022-03-15 filing DRSLTR
- 2022-03-15 filing DRS/A
- 2022-02-14 filing SEC STAFF LETTER
- 2022-02-04 filing UPLOAD
- 2022-01-21 filing DRSLTR
- 2022-01-21 filing DRS/A
- 2021-12-30 filing UPLOAD
- 2021-12-01 filing DRSLTR
- 2021-12-01 filing DRS
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-20 (within 7 days) 6-K filed (FORM 6-K)
- 2026-11-17 (within 7 days) 424B5 filed
- 2026-11-12 (within 30 days) 6-K filed (FORM 6-K)
- 2026-10-19 (older) 6-K filed (FORM 6-K)
- 2026-09-08 (older) 6-K filed (FORM 6-K)
- 2026-08-13 (older) 6-K filed (FORM 6-K)
- 2026-08-11 (older) 6-K filed (FORM 6-K)
- 2026-06-15 (older) 6-K filed (FORM 6-K)
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-21; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:BLTE The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
1 possible match held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1889109 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | BLTE / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| CUSIP | 07782B104 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001889109 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2025-12-31) | -$77,611,000 | 2025-12-31 | 20-F, XBRL NetIncomeLoss | as filed | 2026-11-21 00:39 UTC | Report an error |
| Total assets (at 2025-12-31) | $780,556,000 | 2025-12-31 | 20-F, XBRL Assets | as filed | 2026-11-21 00:39 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $770,486,000 | 2025-12-31 | 20-F, XBRL StockholdersEquity | as filed | 2026-11-21 00:39 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $352,932,000 | 2025-12-31 | 20-F, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-21 00:39 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | other | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-21 00:39 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-21 00:39 UTC | Report an error |
| State of incorporation | E9 | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-21 00:39 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-21 00:39 UTC | Report an error |
| Business address | 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130 | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-21 00:39 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-20 | SEC EDGAR company profile | as filed | 2026-11-21 00:39 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$36,988,000 | 2025-12-31 | 20-F, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-21 00:39 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $71,000 | 2025-12-31 | 20-F, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-21 00:39 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $429,000 | 2025-12-31 | 20-F, XBRL OperatingLeaseLiability | as filed | 2026-11-21 00:39 UTC | Report an error |
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-20 Filing 6-K filed (FORM 6-K)
- 2026-11-17 Filing 424B5 filed
- 2026-11-12 Filing 6-K filed (FORM 6-K)
- 2026-10-19 Filing 6-K filed (FORM 6-K)
- 2026-09-08 Filing 6-K filed (FORM 6-K)
- 2026-08-13 Filing 6-K filed (FORM 6-K)
- 2026-08-11 Filing 6-K filed (FORM 6-K)
- 2026-06-15 Filing 6-K filed (FORM 6-K)
- 2026-05-20 Filing 6-K filed (FORM 6-K)
- 2026-04-21 Filing 6-K filed
- 2026-03-31 Filing 6-K filed (FORM 6-K)
- 2026-03-31 Filing 20-F filed
- 2026-03-02 Filing 6-K filed (FORM 6-K)
- 2026-01-30 Filing S-8 filed (FORM S-8)
- 2026-01-27 Filing 6-K filed (FORM 6-K)
- 2025-12-02 Filing 424B5 filed
- 2025-12-02 Filing 6-K filed (FORM 6-K)
- 2025-12-01 Filing 424B5 filed
- 2025-12-01 Filing 6-K filed (FORM 6-K)
- 2025-12-01 Filing 6-K filed (FORM 6-K)
- 2025-12-01 Filing 6-K filed (FORM 6-K)
- 2025-11-10 Filing 6-K filed (FORM 6-K)
- 2025-10-22 Filing F-3ASR filed
- 2025-09-08 Filing 6-K filed (FORM 6-K)
- 2025-08-11 Filing 6-K filed (FORM 6-K)
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | Darwin Global Management, Ltd. | $456,588,244 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
| 2 | Paradigm Biocapital Advisors LP | $189,844,565 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
| 3 | RTW INVESTMENTS, LP | $110,150,398 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
| 4 | MILLENNIUM MANAGEMENT LLC | $76,155,438 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
| 5 | MAVERICK CAPITAL LTD | $61,025,949 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
| 6 | EVENTIDE ASSET MANAGEMENT, LLC | $60,181,804 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
| 7 | DEERFIELD MANAGEMENT COMPANY, L.P. | $55,003,288 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
| 8 | Holocene Advisors, LP | $38,655,624 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
| 9 | Logos Global Management LP | $38,496,250 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
| 10 | UBS Group AG | $34,644,931 | 2026-06-30 | SEC 13F filing | 2026-11-21 00:39 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchBelite Bio, Inc · exact legal name · sx:ctgov:h520314870b3f5f7e Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1889109.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001889109. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.